Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.73%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +112.51%
#6 Bedrock Bedrock +75.21%
#7 Prom Prom +41.40%
#8 Cysic Cysic +40.00%
#9 Playnance Playnance +34.54%
#10 COTI COTI +29.54%
Coin of the day
Wrapped One Wrapped One
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc.

VRPX
Classifica tra le azioni #42776
Virpax Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical... Virpax Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical enterprise, dedicated to pioneering diverse drug-delivery systems and novel drug-releasing technologies. Its core focus lies in developing advanced, non-opioid and non-addictive solutions for pain management, alongside therapies targeting central nervous system disorders. The company's current investigational pipeline features several preclinical product candidates. These include Epoladerm, a topical nonsteroidal anti-inflammatory drug (NSAID) designed to address chronic osteoarthritis of the knee, and Probudur, an injectable liposomal gel formulated as a local anesthetic for managing post-operative pain. Also in development are Envelta and PES200, both nanotechnology-based intranasal spray drug candidates engineered to deliver metabolically labile peptide drugs directly to the brain. Further candidates comprise AnQlar, an antiviral barrier solution intended to prevent or lessen the severity of human viral infections such as influenza and SARS-CoV-2, and VRP324, an experimental nasal formulation aimed at enhancing the transport of cannabidiol into the brain. Virpax Pharmaceuticals, Inc. was established in 2016 and is based in Berwyn, Pennsylvania.
Prezzo delle azioni
$0.0001
Ultima sincronizzazione: 2026-08-11
Capitalizzazione di mercato
$124.00
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-99.09%
Paese
US
Scambia Virpax Pharmaceuticals, Inc. (VRPX)

Categoria

Healthcare
Il prezzo VRPX con la capitalizzazione del mercato della B
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.
VRPX
$0.0001
Capitalizzazione di mercato di Virpax Pharmaceuticals, Inc.(VRPX)
Capitalizzazione di mercato: $124.00
A partire dal August 2026, Virpax Pharmaceuticals, Inc. ha una capitalizzazione di mercato pari a $124.00. Questo rende Virpax Pharmaceuticals, Inc. la 42776th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di Virpax Pharmaceuticals, Inc. dal 2021 al 2026
VRPX in paragone con la classifica dei più popolari stocks
Il prezzo per VRPX Attivo B Capitalizzazione del mercato a B Risultati
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.
$4,375,797 $124.00
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.426T +4,375,797,196,257.26%
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.
$3,578,148 $124.00
Apple Inc. Apple Inc.
AAPL
$4.437T +3,578,147,882,190.32%
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.
$3,346,279 $124.00
Alphabet Inc. Alphabet Inc.
GOOG
$4.149T +3,346,279,360,676.61%
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.
$2,954,710 $124.00
Microsoft Corporation Microsoft Corporation
MSFT
$3.664T +2,954,710,181,754.84%
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.
$2,330,040 $124.00
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.889T +2,330,039,910,383.87%